<DOC>
	<DOC>NCT01591044</DOC>
	<brief_summary>The purpose of this study is to determine the safety, efficacy and tolerability of R940343 in the treatment of mild to moderate asthma.</brief_summary>
	<brief_title>A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma</brief_title>
	<detailed_description>The study is a multi-center, randomized, double-blind, placebo-controlled, parallel group study comparing 2 doses of inhaled R343 bid to placebo over 8 weeks in patients with mild to moderate allergic asthma. Patients who meet specific inclusion and exclusion criteria after an initial screening evaluation and a single-blind, run-in period will be randomized to receive either R343 or placebo.</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Clinical history of asthma Ability to perform spirometry Chronic obstructive pulmonary disease or bronchiectasis Upper or lower respiratory infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>